Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 15 Jan 2026 for Acura Pharmaceuticals, INC.
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Immanuel Thangaraj: trading record in brief
Immanuel Thangaraj, listed as board member, appears in our data through filings on Acura Pharmaceuticals, Inc shares, published by SEC (Form 4). Over a trading history stretching from 31 March 2005 to 2 January 2026, the count stands at 27 filings.
Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The newest entry dates from 15 January 2026: an option exercise, in Acura Pharmaceuticals, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 22 days. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Immanuel Thangaraj
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
50,000 sharesCommon StockSEC:0001104659-26-004053:0
50,000 sharesCommon StockSEC:0001104659-25-008916:0
50,000 sharesCommon StockSEC:0001104659-24-000284:0
66,666 sharesCommon StockSEC:0001104659-23-001403:0
66,666 sharesCommon StockSEC:0001104659-22-003594:0
6,185 sharesCommon StockSEC:0001209191-16-089763:0
6 of 6 declarations
